lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
2017 · Nature Medicine · 449 citations
https://doi.org/10.1038/nm.4424
M
Mingli Yang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.1K
Citations
22
h-index
35
i10-index
Mingli Yang is an academic researcher from University of South Florida. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 22, co-authored 84 publications.
ORCID: 0000-0002-4781-690XPapers by this author
worksA multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
2016 · Nature Communications · 211 citations
https://doi.org/10.1038/ncomms11743
Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery
2014 · Journal of Hematology & Oncology · 65 citations
https://doi.org/10.1186/1756-8722-7-5
Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
2015 · International Journal of Molecular Sciences · 37 citations
https://doi.org/10.3390/ijms161125998
Eriodictyol Inhibits RANKL‐Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity
2016 · Journal of Cellular Physiology · 30 citations
https://doi.org/10.1002/jcp.25304
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation
2018 · Scientific Reports · 25 citations
https://doi.org/10.1038/s41598-018-27584-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat